Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis
Journal of the American Academy of Dermatology | Aug 04, 2019
Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study
Journal of the American Academy of Dermatology | Aug 04, 2019